Connect with us

HEALTH

Three states lead Nigeria’s Lassa fever toll with 70% cases – NCDC

Published

on

HREE states recorded 70 per cent of Nigeria’s the 909 confirmed cases of Lassa fever.

  A post on Nigeria Centre for Disease Control (NCDC)’s verified website said out of 815 suspected cases of Monkey pox recorded in the country recorded in the ongoing year, 318 cases were confirmed cases while death toll rose to seven.

  This brings total number of confirmed cases so far to 909 with 170 deaths arising from 25 states and 101 local government areas.

  Also, giving update on COVID-19, NCDC said 5,547,250 samples have so far been tested with 264,802 confirmed cases while 257,880 infected persons were discharged. Unfortunately, he said, 909 3,155 deaths have been recorded.

  Speaking on measles, the post said impacts of COVID-19 continue to be felt across several other areas including the increase in the risk of measles and a probable increase in yellow fever outbreaks due to delayed planned vaccination campaigns.

  Also giving an update on monkeypox, the post indicates that Nigeria has 815 suspected cases, 318 confirmed cases, and 7 deaths this year from the outbreak.

  “Globally, since January 1, 2022, 102 member states have reported more than 52,000 laboratory-confirmed cases to WHO, including 18 deaths.

  “Our response continues with the development of monkeypox risk communication materials, provision of support to states with case identification, SORMAS reporting also.

 With regards to infection, prevention and control, we continue to train IPC focal persons, and develop IPC guidelines. Laboratory activities have continued and are being strengthened in areas of sample collection, and genomic sequencing.

You May Also Like:-  Group pays medical bills of indigent patients

We recently held a meeting with key partner support, establishing areas of monkeypox research priorities including understanding animal reservoirs, population exposure, and genomics of transmission chains,” the post reads further.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.